<<

. 2
( 2 .)



Jul;27(7):676–80.
12. Gleiter CH, Schreeb KH, Freudenthaler S. Comparative
bioavailability of two vitamin Bl preparations: Benfotiamin and
thiamin mononitrate. In Gries FA, Federlin K. Benfotiamin in
the Therapy of Polyneuropathy. New York: Georg Thieme Verlag,
7998/29–33.
?en. 6. Eciaiaiea noauaeoeaiuo i?eciaeia iae?iiaoee
13. Grefo A, Bi’fsch R. Comparative bioavailability of various
(oeaea TSS) iinea ea?aiey
thiamin derivatives after oral
administration. Int J Clin Pharmacol Ther. 7998
Apr/36(4).–276–27.
14. Bitsch R. Lipidlosliche thiaminederivate. Deutsche
Apotheker Zeitung. 1989; 1 29:
65–8. Cited by (69,73).
15. Heinrich HC. Thiamin– und folsauremangel bet chronischem
alkoholismus, eisen– und cobalaminmangel be/ veganischer
erndhrung. frndhrungs–Umschau. 7990;37:594–607.
16. Frank T, Bitsch R, Maiwald J, Stein G. High thiamin diphos-
phate concentrations in erythrocytes can be achieved in dialy-
sis patients by oral administration of Benfotiaminntiamine. fur
J Clin Pharmacol. 2000 Jun;56(3):251–7.
17. Hammes HP, Bretzel RGt Federlin K, Horiuchi S, Niwa T,
Stracke H, Benfotiamin inhibits the formation of advanced gly-
cation endproducts in diabetic rats. Diabetologia. 1998
Aug;41(Supp 1):A301(1164).
18. Stracke H, Lindemann A, Federlin K. A Benfotiamin–vitamin
combination in treatment of diabetic pol/neuropathy. Exp Clin
Endocrinol Diabetes. 1996;104(4):31 1–6.
19. Haupt E, Ledermann H, Kopcke W. Diabetic polyneuropathy:
the effectiveness of Benfotiamin in Pain. In Gries FA, Federlin
K. Benfotiamin in the Therapy of Polyneuropathy. New York:
?en. 7. Eciaiaiea iauaeoeaiuo i?eciaeia iae?iiaoee Georg Thieme Verlag, 1998;61–4.
(oeaea NIS LL) iinea ea?aiey [23] 20. Ledermann H, Wiedey KD. Treatment of manifest diabetic
polyneuropathy. Therapeutic effect of a neurotropic vitamin
1–6–12 combination. Therapiewoche. 1989;39(20): 1445–9.
21. Simeonov S, Pavlova M, Mitkov M, Mincheva L, Troev D.
Eiee?anoai aaneeaoi?iuo eaieeey?iuo




Therapeutic efficacy of
«Milgamma» in patients with painful diabetic neuropathy. Folia
Med (Plovdiv).1997;39(4):5–10.
22. Jermendy G. Diabetic polyneuropathy: results of an open
naaiaioia ia ii2




multicenter study. In Gries FA, Federlin K. Benfotiamin in the
Therapy of Polyneuropathy. New York: Georg Thieme Verlag,
1998;71–6.
23. ..
-
.
24. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, ju
Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld
R, Giardino I, Brownlee M. Benfotiamine blocks three major
pathways of hyperglycemic damage and prevents experimental
retinopathy. Nat Med. 2003 Mar, –9(3): 294–9.
25. http: //www.jdrf.org.uk/projects/thornalley.htm




?en. 8. Eiee?anoai aaneeaoi?iuo eaieeey?ia i?e ea?aiee
aaioioeaieiii o yenia?eiaioaeuiuo ?eaioiuo [25]



1002 13, 15, 2005

<<

. 2
( 2 .)